 | • レポートコード：MRC2102QY15231 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の経皮的神経刺激装置市場について種類別（仙骨神経、迷走神経、脳、その他）、用途別（アルツハイマー病、胃不全麻痺、失禁、パーキンソン病、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・経皮的神経刺激装置市場の概要 ・世界の主要地域別経皮的神経刺激装置市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の経皮的神経刺激装置市場規模2015-2026：種類別（仙骨神経、迷走神経、脳、その他） ・世界の経皮的神経刺激装置市場規模2015-2026：用途別（アルツハイマー病、胃不全麻痺、失禁、パーキンソン病、その他） ・経皮的神経刺激装置の米国市場規模2015-2020 ・経皮的神経刺激装置のヨーロッパ市場規模2015-2020 ・経皮的神経刺激装置の中国市場規模2015-2020 ・経皮的神経刺激装置の日本市場規模2015-2020 ・経皮的神経刺激装置の東南アジア市場規模2015-2020 ・経皮的神経刺激装置のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・経皮的神経刺激装置の製造コスト分析 ・販売チャネル、流通業者、顧客 ・経皮的神経刺激装置の市場動向・機会・課題 ・調査の結論 |
Transcutaneous electrical nerve stimulation (TENS) is a therapy that uses low voltage electrical current to provide pain relief. A TENS unit consists of a battery-powered device that delivers electrical impulses through electrodes placed on the surface of your skin.
Market Analysis and Insights: Global Transcutaneous Neurostimulator Market
The global Transcutaneous Neurostimulator market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Transcutaneous Neurostimulator Scope and Market Size
The global Transcutaneous Neurostimulator market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transcutaneous Neurostimulator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Transcutaneous Neurostimulator market is segmented into
Sacral Nerves
Vagus Nerves
Brain
Others
Segment by Application, the Transcutaneous Neurostimulator market is segmented into
Alzheimer’s Disease
Gastroparesis
Incontinence
Parkinson’s Disease
Others
The Transcutaneous Neurostimulator market is analysed and market size information is provided by regions (countries). Segment by Application, the Transcutaneous Neurostimulator market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transcutaneous Neurostimulator Market Share Analysis
Transcutaneous Neurostimulator market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transcutaneous Neurostimulator business, the date to enter into the Transcutaneous Neurostimulator market, Transcutaneous Neurostimulator product introduction, recent developments, etc.
The major vendors covered:
Medtronic
Apnex Medical
BioMedical Life Systems
Boston Scientific Corporation
Cochlear LTD
DJO
Dynatronics Corporation
ReShape Lifesciences
MED-EL Corporation
Abbott
1 Transcutaneous Neurostimulator Market Overview
1.1 Transcutaneous Neurostimulator Product Scope
1.2 Transcutaneous Neurostimulator Segment by Type
1.2.1 Global Transcutaneous Neurostimulator Sales by Type (2020-2026)
1.2.2 Sacral Nerves
1.2.3 Vagus Nerves
1.2.4 Brain
1.2.5 Others
1.3 Transcutaneous Neurostimulator Segment by Application
1.3.1 Global Transcutaneous Neurostimulator Sales Comparison by Application (2020-2026)
1.3.2 Alzheimer’s Disease
1.3.3 Gastroparesis
1.3.4 Incontinence
1.3.5 Parkinson’s Disease
1.3.6 Others
1.4 Transcutaneous Neurostimulator Market Estimates and Forecasts (2015-2026)
1.4.1 Global Transcutaneous Neurostimulator Sales Growth Rate (2015-2026)
1.4.2 Global Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2026)
1.4.3 Global Transcutaneous Neurostimulator Price Trends (2015-2026)
2 Transcutaneous Neurostimulator Estimate and Forecast by Region
2.1 Global Transcutaneous Neurostimulator Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Transcutaneous Neurostimulator Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Transcutaneous Neurostimulator Sales Market Share by Region (2015-2020)
2.2.2 Global Transcutaneous Neurostimulator Revenue Market Share by Region (2015-2020)
2.3 Global Transcutaneous Neurostimulator Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Transcutaneous Neurostimulator Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Transcutaneous Neurostimulator Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
2.4.2 Europe Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
2.4.3 China Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
2.4.4 Japan Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
2.4.6 India Transcutaneous Neurostimulator Estimates and Projections (2015-2026)
3 Global Transcutaneous Neurostimulator Competition Landscape by Players
3.1 Global Top Transcutaneous Neurostimulator Players by Sales (2015-2020)
3.2 Global Top Transcutaneous Neurostimulator Players by Revenue (2015-2020)
3.3 Global Transcutaneous Neurostimulator Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transcutaneous Neurostimulator as of 2019)
3.4 Global Transcutaneous Neurostimulator Average Price by Company (2015-2020)
3.5 Manufacturers Transcutaneous Neurostimulator Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Transcutaneous Neurostimulator Players (Opinion Leaders)
4 Global Transcutaneous Neurostimulator Market Size by Type
4.1 Global Transcutaneous Neurostimulator Historic Market Review by Type (2015-2020)
4.1.1 Global Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
4.1.2 Global Transcutaneous Neurostimulator Revenue Market Share by Type (2015-2020)
4.1.3 Global Transcutaneous Neurostimulator Price by Type (2015-2020)
4.2 Global Transcutaneous Neurostimulator Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Transcutaneous Neurostimulator Sales Forecast by Type (2021-2026)
4.2.2 Global Transcutaneous Neurostimulator Revenue Forecast by Type (2021-2026)
4.2.3 Global Transcutaneous Neurostimulator Price Forecast by Type (2021-2026)
5 Global Transcutaneous Neurostimulator Market Size by Application
5.1 Global Transcutaneous Neurostimulator Historic Market Review by Application (2015-2020)
5.1.1 Global Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
5.1.2 Global Transcutaneous Neurostimulator Revenue Market Share by Application (2015-2020)
5.1.3 Global Transcutaneous Neurostimulator Price by Application (2015-2020)
5.2 Global Transcutaneous Neurostimulator Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Transcutaneous Neurostimulator Sales Forecast by Application (2021-2026)
5.2.2 Global Transcutaneous Neurostimulator Revenue Forecast by Application (2021-2026)
5.2.3 Global Transcutaneous Neurostimulator Price Forecast by Application (2021-2026)
6 United States Transcutaneous Neurostimulator Market Facts & Figures
6.1 United States Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
6.2 United States Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
6.3 United States Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
7 Europe Transcutaneous Neurostimulator Market Facts & Figures
7.1 Europe Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
7.2 Europe Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
7.3 Europe Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
8 China Transcutaneous Neurostimulator Market Facts & Figures
8.1 China Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
8.2 China Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
8.3 China Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
9 Japan Transcutaneous Neurostimulator Market Facts & Figures
9.1 Japan Transcutaneous Neurostimulator Sales Market Share by Company (3015-3030)
9.2 Japan Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
9.3 Japan Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
10 Southeast Asia Transcutaneous Neurostimulator Market Facts & Figures
10.1 Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
11 India Transcutaneous Neurostimulator Market Facts & Figures
11.1 India Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
11.2 India Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
11.3 India Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Transcutaneous Neurostimulator Business
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Business Overview
12.1.3 Medtronic Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic Transcutaneous Neurostimulator Products Offered
12.1.5 Medtronic Recent Development
12.2 Apnex Medical
12.2.1 Apnex Medical Corporation Information
12.2.2 Apnex Medical Business Overview
12.2.3 Apnex Medical Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Apnex Medical Transcutaneous Neurostimulator Products Offered
12.2.5 Apnex Medical Recent Development
12.3 BioMedical Life Systems
12.3.1 BioMedical Life Systems Corporation Information
12.3.2 BioMedical Life Systems Business Overview
12.3.3 BioMedical Life Systems Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BioMedical Life Systems Transcutaneous Neurostimulator Products Offered
12.3.5 BioMedical Life Systems Recent Development
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Corporation Information
12.4.2 Boston Scientific Corporation Business Overview
12.4.3 Boston Scientific Corporation Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boston Scientific Corporation Transcutaneous Neurostimulator Products Offered
12.4.5 Boston Scientific Corporation Recent Development
12.5 Cochlear LTD
12.5.1 Cochlear LTD Corporation Information
12.5.2 Cochlear LTD Business Overview
12.5.3 Cochlear LTD Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cochlear LTD Transcutaneous Neurostimulator Products Offered
12.5.5 Cochlear LTD Recent Development
12.6 DJO
12.6.1 DJO Corporation Information
12.6.2 DJO Business Overview
12.6.3 DJO Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.6.4 DJO Transcutaneous Neurostimulator Products Offered
12.6.5 DJO Recent Development
12.7 Dynatronics Corporation
12.7.1 Dynatronics Corporation Corporation Information
12.7.2 Dynatronics Corporation Business Overview
12.7.3 Dynatronics Corporation Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dynatronics Corporation Transcutaneous Neurostimulator Products Offered
12.7.5 Dynatronics Corporation Recent Development
12.8 ReShape Lifesciences
12.8.1 ReShape Lifesciences Corporation Information
12.8.2 ReShape Lifesciences Business Overview
12.8.3 ReShape Lifesciences Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ReShape Lifesciences Transcutaneous Neurostimulator Products Offered
12.8.5 ReShape Lifesciences Recent Development
12.9 MED-EL Corporation
12.9.1 MED-EL Corporation Corporation Information
12.9.2 MED-EL Corporation Business Overview
12.9.3 MED-EL Corporation Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.9.4 MED-EL Corporation Transcutaneous Neurostimulator Products Offered
12.9.5 MED-EL Corporation Recent Development
12.10 Abbott
12.10.1 Abbott Corporation Information
12.10.2 Abbott Business Overview
12.10.3 Abbott Transcutaneous Neurostimulator Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Abbott Transcutaneous Neurostimulator Products Offered
12.10.5 Abbott Recent Development
13 Transcutaneous Neurostimulator Manufacturing Cost Analysis
13.1 Transcutaneous Neurostimulator Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transcutaneous Neurostimulator
13.4 Transcutaneous Neurostimulator Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transcutaneous Neurostimulator Distributors List
14.3 Transcutaneous Neurostimulator Customers
15 Market Dynamics
15.1 Transcutaneous Neurostimulator Market Trends
15.2 Transcutaneous Neurostimulator Opportunities and Drivers
15.3 Transcutaneous Neurostimulator Market Challenges
15.4 Transcutaneous Neurostimulator Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Transcutaneous Neurostimulator Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Transcutaneous Neurostimulator Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Transcutaneous Neurostimulator Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Transcutaneous Neurostimulator Sales (K Units) by Region (2015-2020)
Table 5. Global Transcutaneous Neurostimulator Sales Market Share by Region (2015-2020)
Table 6. Global Transcutaneous Neurostimulator Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Transcutaneous Neurostimulator Revenue Share by Region (2015-2020)
Table 8. Global Transcutaneous Neurostimulator Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Transcutaneous Neurostimulator Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Transcutaneous Neurostimulator Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Transcutaneous Neurostimulator Revenue Share Forecast by Region (2021-2026)
Table 12. Global Transcutaneous Neurostimulator (K Units) of Key Companies (2015-2020)
Table 13. Global Transcutaneous Neurostimulator Sales Share by Company (2015-2020)
Table 14. Global Transcutaneous Neurostimulator Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Transcutaneous Neurostimulator Revenue Share by Company (2015-2020)
Table 16. Global Transcutaneous Neurostimulator by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transcutaneous Neurostimulator as of 2019)
Table 17. Global Transcutaneous Neurostimulator Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Transcutaneous Neurostimulator Manufacturing Sites and Area Served
Table 19. Manufacturers Transcutaneous Neurostimulator Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Transcutaneous Neurostimulator Players
Table 22. Global Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 23. Global Transcutaneous Neurostimulator Sales Share by Type (2015-2020)
Table 24. Global Transcutaneous Neurostimulator Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Transcutaneous Neurostimulator Price (K Units) by Type (2015-2020)
Table 26. Global Transcutaneous Neurostimulator Sales Share by Type (2021-2026)
Table 27. Global Transcutaneous Neurostimulator Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Transcutaneous Neurostimulator Revenue Share by Type (2021-2026)
Table 29. Global Transcutaneous Neurostimulator Price (K Units) by Type (2021-2026)
Table 30. Global Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 31. Global Transcutaneous Neurostimulator Sales Share by Application (2015-2020)
Table 32. Global Transcutaneous Neurostimulator Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Transcutaneous Neurostimulator Price (K Units) by Application (2015-2020)
Table 34. Global Transcutaneous Neurostimulator Sales (K Units) by Application (2021-2026)
Table 35. Global Transcutaneous Neurostimulator Sales Share by Application (2021-2026)
Table 36. Global Transcutaneous Neurostimulator Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Transcutaneous Neurostimulator Revenue Share by Application (2021-2026)
Table 38. Global Transcutaneous Neurostimulator Price (K Units) by Application (2021-2026)
Table 39. United States Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 40. United States Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 41. United States Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 42. United States Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 43. United States Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 44. United States Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
Table 45. Europe Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 46. Europe Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 47. Europe Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 48. Europe Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 49. Europe Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 50. Europe Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 51. China Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 52. China Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 53. China Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 54. China Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 55. China Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 56. China Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
Table 57. Japan Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 58. Japan Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 59. Japan Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 60. Japan Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 61. Japan Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 62. Japan Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
Table 69. India Transcutaneous Neurostimulator Sales (K Units) by Company (2015-2020)
Table 70. India Transcutaneous Neurostimulator Sales Market Share by Company (2015-2020)
Table 71. India Transcutaneous Neurostimulator Sales (K Units) by Type (2015-2020)
Table 72. India Transcutaneous Neurostimulator Sales Market Share by Type (2015-2020)
Table 73. India Transcutaneous Neurostimulator Sales (K Units) by Application (2015-2020)
Table 74. India Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Medtronic Transcutaneous Neurostimulator Product
Table 79. Medtronic Recent Development
Table 80. Apnex Medical Corporation Information
Table 81. Apnex Medical Description and Business Overview
Table 82. Apnex Medical Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Apnex Medical Transcutaneous Neurostimulator Product
Table 84. Apnex Medical Recent Development
Table 85. BioMedical Life Systems Corporation Information
Table 86. BioMedical Life Systems Description and Business Overview
Table 87. BioMedical Life Systems Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. BioMedical Life Systems Transcutaneous Neurostimulator Product
Table 89. BioMedical Life Systems Recent Development
Table 90. Boston Scientific Corporation Corporation Information
Table 91. Boston Scientific Corporation Description and Business Overview
Table 92. Boston Scientific Corporation Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boston Scientific Corporation Transcutaneous Neurostimulator Product
Table 94. Boston Scientific Corporation Recent Development
Table 95. Cochlear LTD Corporation Information
Table 96. Cochlear LTD Description and Business Overview
Table 97. Cochlear LTD Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cochlear LTD Transcutaneous Neurostimulator Product
Table 99. Cochlear LTD Recent Development
Table 100. DJO Corporation Information
Table 101. DJO Description and Business Overview
Table 102. DJO Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. DJO Transcutaneous Neurostimulator Product
Table 104. DJO Recent Development
Table 105. Dynatronics Corporation Corporation Information
Table 106. Dynatronics Corporation Description and Business Overview
Table 107. Dynatronics Corporation Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Dynatronics Corporation Transcutaneous Neurostimulator Product
Table 109. Dynatronics Corporation Recent Development
Table 110. ReShape Lifesciences Corporation Information
Table 111. ReShape Lifesciences Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. ReShape Lifesciences Description and Business Overview
Table 113. ReShape Lifesciences Transcutaneous Neurostimulator Product
Table 114. ReShape Lifesciences Recent Development
Table 115. MED-EL Corporation Corporation Information
Table 116. MED-EL Corporation Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. MED-EL Corporation Description and Business Overview
Table 118. MED-EL Corporation Transcutaneous Neurostimulator Product
Table 119. MED-EL Corporation Recent Development
Table 120. Abbott Corporation Information
Table 121. Abbott Description and Business Overview
Table 122. Abbott Transcutaneous Neurostimulator Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Abbott Transcutaneous Neurostimulator Product
Table 124. Abbott Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Transcutaneous Neurostimulator Distributors List
Table 128. Transcutaneous Neurostimulator Customers List
Table 129. Transcutaneous Neurostimulator Market Key Trends
Table 130. Transcutaneous Neurostimulator Key Opportunities and Drivers
Table 131. Transcutaneous Neurostimulator Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcutaneous Neurostimulator Product Picture
Figure 2. Global Transcutaneous Neurostimulator Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transcutaneous Neurostimulator Market Share by Application in 2020 & 2026
Figure 6. Alzheimer's Disease Examples
Figure 7. Gastroparesis Examples
Figure 8. Incontinence Examples
Figure 9. Parkinson's Disease Examples
Figure 10. Others Examples
Figure 11. Global Transcutaneous Neurostimulator Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Transcutaneous Neurostimulator Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Transcutaneous Neurostimulator Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Transcutaneous Neurostimulator Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Transcutaneous Neurostimulator Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Transcutaneous Neurostimulator Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Transcutaneous Neurostimulator Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Transcutaneous Neurostimulator Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Transcutaneous Neurostimulator Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Transcutaneous Neurostimulator Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Transcutaneous Neurostimulator Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Transcutaneous Neurostimulator Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Transcutaneous Neurostimulator Players Market Share by Revenue in Transcutaneous Neurostimulator 2015 & 2019
Figure 29. Transcutaneous Neurostimulator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Transcutaneous Neurostimulator Revenue Share by Type (2015-2020)
Figure 31. Global Transcutaneous Neurostimulator Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Transcutaneous Neurostimulator Revenue Share by Application (2015-2020)
Figure 33. Global Transcutaneous Neurostimulator Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 35. United States Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 36. Europe Transcutaneous Neurostimulator Sales Market Share by Company in 2019
Figure 37. Europe Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 38. Europe Transcutaneous Neurostimulator Sales Market Share by Application in 2019
Figure 39. China Transcutaneous Neurostimulator Sales Market Share by Company in 2019
Figure 40. China Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 41. China Transcutaneous Neurostimulator Sales Market Share by Application in 2019
Figure 42. Japan Transcutaneous Neurostimulator Sales Market Share by Company in 2019
Figure 43. Japan Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 44. Japan Transcutaneous Neurostimulator Sales Market Share by Application in 2019
Figure 45. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Company in 2019
Figure 46. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 47. Southeast Asia Transcutaneous Neurostimulator Sales Market Share by Application in 2019
Figure 48. India Transcutaneous Neurostimulator Sales Market Share by Company in 2019
Figure 49. India Transcutaneous Neurostimulator Sales Market Share by Type in 2019
Figure 50. India Transcutaneous Neurostimulator Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Transcutaneous Neurostimulator
Figure 53. Manufacturing Process Analysis of Transcutaneous Neurostimulator
Figure 54. Transcutaneous Neurostimulator Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
経皮的酸素モニターの世界市場レポート2020 Transcutaneous Oxygen Monitor is the device used for transcutaneous oximetry (TcPO2 or TCOM), which is a local, non-invasive measurement reflecting the amount of O2 that has diffused from the capillaries through the epidermis. Today, transcutaneous oxygen monitoring is clinically prevalent in variou…- 血液脳関門輸送薬の世界市場レポート2020 Market Analysis and Insights: Global Blood-Brain Barrier Transport Drugs Market The global Blood-Brain Barrier Transport Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Blood-Brain Barrier Transport Drugs Scope an…
- 胃不全麻痺薬の世界市場レポート2020 Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents. North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America. Market…
- 迷走神経刺激（VNS）装置の世界市場レポート2020 Market Analysis and Insights: Global Vagus Nerve Stimulation Devices Market The global Vagus Nerve Stimulation Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vagus Nerve Stimulation Devices Scope and Market Siz…
- ビリルビンメーターの世界市場レポート2020 Bilirubin (formerly referred to as haematoidin and discovered by Rudolf Virchow in 1847) is a yellow compound that occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products that arise from the destruc…